J. L. Bainbridge & Co., Inc. - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 47 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. L. Bainbridge & Co., Inc. ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,191
-38.8%
11,121
+4.7%
0.00%
-50.0%
Q2 2023$13,382
+73.8%
10,6210.0%0.00%
+100.0%
Q1 2023$7,699
+37.2%
10,6210.0%0.00%0.0%
Q4 2022$5,613
-37.6%
10,6210.0%0.00%0.0%
Q3 2022$9,000
-25.0%
10,6210.0%0.00%
-50.0%
Q2 2022$12,000
-7.7%
10,6210.0%0.00%
+100.0%
Q1 2022$13,000
-23.5%
10,6210.0%0.00%
-50.0%
Q4 2021$17,000
-51.4%
10,6210.0%0.00%
-50.0%
Q3 2021$35,000
-47.8%
10,6210.0%0.00%
-50.0%
Q2 2021$67,00010,6210.01%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 524,805$572,0000.39%
Laurion Capital Management LP 2,225,800$2,426,0000.04%
Ergoteles LLC 514,600$561,0000.02%
Pinz Capital Management, LP 17,900$20,0000.01%
Alpine Global Management, LLC 37,089$40,0000.01%
Game Plan Financial Advisors, LLC 10,000$11,0000.01%
Spire Wealth Management 100,300$109,0000.00%
Renaissance Technologies 1,989,995$2,169,0000.00%
D. E. Shaw & Co., Inc. 2,279,636$2,485,0000.00%
Y-Intercept (Hong Kong) Ltd 16,912$18,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders